| CGNGX | PAECX | CGNGX / PAECX | |
| Total Expense Ratio | 0.57 | 1.76 | 32% |
| Annual Report Gross Expense Ratio | 0.62 | 1.76 | 35% |
| Fund Existence | 8 years | 31 years | - |
| Gain YTD | 2.157 | 1.443 | 149% |
| Front Load | 6% | N/A | - |
| Min. Initial Investment | 250 | 0 | - |
| Min. Initial Investment IRA | N/A | N/A | - |
| Net Assets | 21.9B | 3.06B | 717% |
| Annual Yield % from dividends | 1.72 | 1.12 | 155% |
| Returns for 1 year | 16.70 | 13.64 | 122% |
| Returns for 3 years | 46.56 | 37.16 | 125% |
| Returns for 5 years | 36.90 | 15.57 | 237% |
| Returns for 10 years | N/A | 61.87 | - |
| 1 Day | |||
|---|---|---|---|
| MFs / NAME | Price $ | Chg $ | Chg % |
| BHSRX | 63.19 | 0.56 | +0.89% |
| BlackRock Health Sciences Opps R | |||
| AEGMX | 16.06 | -0.06 | -0.37% |
| American Century Emerging Markets R5 | |||
| EEIFX | 10.63 | -0.04 | -0.37% |
| Monteagle Enhanced Equity Income Instl | |||
| AWSIX | 17.09 | -0.08 | -0.47% |
| Invesco Global Core Equity R5 | |||
| BLYYX | 34.53 | -0.46 | -1.31% |
| American Beacon Man Lg Cp Growth Y | |||